Sun Pharmaceutical Industries Limited has informed the Exchange about Filing of Application for reclassification with stock exchanges
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sun Pharmaceutical Industries has filed an application with NSE and BSE on 26 May 2026 seeking no-objection or approval for the reclassification of an entity from the 'Promoter Group' category to the 'Public' category, under Regulation 31A of SEBI Listing Regulations. This follows earlier intimations dated 14 May 2026 and 22 May 2026, indicating the process has been underway. The company states the filing is in compliance with SEBI LODR provisions. The specific entity being reclassified is not named in the filing.
Reclassification from Promoter Group to Public typically signals a reduction in promoter-group influence or a potential stake sale/exit by a related entity, which could affect the company's governance dynamics and shareholding structure. Investors should monitor for subsequent disclosures on shareholding pattern changes.